Metraipolis › archive › dc_51bc669e91d4

Thykamine™: A New Player in the Field of Anti-Inflammatory Drugs — Europe PMC PMID:41462950

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41462950
DOI
10.3390/biomedicines13122938
License (as archived)
solo-consultazione
Archived
2026-11-08T04:00:46.098Z
SHA-256 of the archived text
6e4d7775b6b2f47ec8f6e81a3b515656aecb38c6a5e261d8ea0ac6fe4391e83b
Stable URL of this page
https://metraipolis.com/documento/dc_51bc669e91d4

How to cite

Thykamine™: A New Player in the Field of Anti-Inflammatory Drugs — Europe PMC PMID:41462950 — Europe PMC (en), https://europepmc.org/article/MED/41462950 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_51bc669e91d4 (Metraipolis archive dc_51bc669e91d4, sha256 6e4d7775b6b2f47ec8f6e81a3b515656aecb38c6a5e261d8ea0ac6fe4391e83b)
BibTeX
@misc{dc51bc669e91d4,
  title = {Thykamine™: A New Player in the Field of Anti-Inflammatory Drugs — Europe PMC PMID:41462950},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41462950},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_51bc669e91d4; sha256 6e4d7775b6b2f47ec8f6e81a3b515656aecb38c6a5e261d8ea0ac6fe4391e83b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41462950. Agents can read the archived copy with the MCP tool read_document.